Fidelity Investments
JBIO

Fidelity Investments’s Jade Biosciences JBIO Stock Holding History

Fidelity Investments’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.6M Buy
7,085,423
+190,935
+3% +$2.76M 0.01% 1182
2025
Q4 		$106M Buy
6,894,488
+2,005,707
+41% +$23.5M 0.01% 1151
2025
Q3 		$42.2M Buy
4,888,781
+53,398
+1% +$436K ﹤0.01% 1498
2025
Q2 		$48.3M Buy
4,835,383
+4,834,990
+1,230,277% +$165M ﹤0.01% 1414
2025
Q1 		$34.5K Sell
393
-5
-1% -$439 ﹤0.01% 4022
2024
Q4 		$36.9K Sell
398
-1,971
-83% -$170K ﹤0.01% 3987
2024
Q3 		$173K Buy
2,369
+2,365
+59,125% +$153K ﹤0.01% 3246
2024
Q2 		$254 Sell
4
-15,354
-100% -$10.2M ﹤0.01% 4910
2024
Q1 		$15.9M Buy
15,358
+1
+0% +$764 ﹤0.01% 1734
2023
Q4 		$12.2M Buy
15,357
+227
+2% +$116K ﹤0.01% 1787
2023
Q3 		$7.19M Sell
15,130
-5,659
-27% -$3.07M ﹤0.01% 1928
2023
Q2 		$12.5M Buy
20,789
+4,476
+27% +$2.86M ﹤0.01% 1790
2023
Q1 		$11.5M Buy
16,313
+3,251
+25% +$2.7M ﹤0.01% 1819
2022
Q4 		$13.4M Sell
13,062
-1,940
-13% -$1.41M ﹤0.01% 1777
2022
Q3 		$8.71M Sell
15,002
-3,134
-17% -$2.09M ﹤0.01% 1964
2022
Q2 		$9.92M Sell
18,136
-2,420
-12% -$1.16M ﹤0.01% 1971
2022
Q1 		$13.2M Buy
20,556
+32
+0.2% +$12.4K ﹤0.01% 2005
2021
Q4 		$8.47M Hold
20,524
– – ﹤0.01% 2178
2021
Q3 		$15.1M Sell
20,524
-5,071
-20% -$2.84M ﹤0.01% 1958
2021
Q2 		$22.2M Buy
+25,595
New +$20.5M ﹤0.01% 1809

Other funds holding JBIO

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Fidelity Investments's JBIO Position: Q1 2026 in Review

Fidelity Investments increased its Jade Biosciences (JBIO) stake by 2.8% in Q1 2026, buying an estimated $2.76M and bringing the position to 7,085,423 shares worth $99.6M. The position accounts for 0.01% of the portfolio, ranked #1182.

Fidelity Investments first reported a position in JBIO in Q2 2021 and has held it in 20 quarters since. The position peaked at $106M in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Fidelity Investments held 7,085,423 shares of Jade Biosciences worth $99.6M as of Q1 2026.
  • Fidelity Investments bought 190,935 Jade Biosciences shares in Q1 2026, an estimated $2.76M.
  • Jade Biosciences made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #1182 holding.
  • Fidelity Investments first reported a position in Jade Biosciences in Q2 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Jade Biosciences position peaked at $106M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.